Cargando…

Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis

In this review, we summarize the most important recent developments in the treatment of amyotrophic lateral sclerosis (ALS). In terms of disease-modifying treatment options, several drugs such as dexpramipexole, pioglitazone, lithium, and many others have been tested in large multicenter trials, alb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorst, Johannes, Ludolph, Albert C., Huebers, Annemarie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784546/ https://www.ncbi.nlm.nih.gov/pubmed/29399045 http://dx.doi.org/10.1177/1756285617734734

Ejemplares similares

Non-invasive ventilation in amyotrophic lateral sclerosis
por: Dorst, Johannes, et al.
Publicado: (2019)

Sequential alterations in diffusion metrics as correlates of disease severity in amyotrophic lateral sclerosis
por: Müller, Hans-Peter, et al.
Publicado: (2023)

Pharyngeal electrical stimulation in amyotrophic lateral sclerosis: a pilot study
por: Herrmann, Christine, et al.
Publicado: (2022)

Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A tract of interest-based MRI study
por: Müller, Hans-Peter, et al.
Publicado: (2018)

Skeletal muscle in amyotrophic lateral sclerosis
por: Shefner, Jeremy M, et al.
Publicado: (2023)

Diffusion Tensor Imaging in Amyotrophic Lateral Sclerosis: Machine Learning for Biomarker Development
por: Behler, Anna, et al.
Publicado: (2023)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
por: Becker, Wolfgang, et al.
Publicado: (2019)

The Fragile X Protein Family in Amyotrophic Lateral Sclerosis
por: Mueller, Sarah, et al.
Publicado: (2023)

Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials
por: Witzel, Simon, et al.
Publicado: (2021)

Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
por: Benatar, Michael, et al.
Publicado: (2021)

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
por: Steinacker, Petra, et al.
Publicado: (2011)

A natural history comparison of SOD1-mutant patients with amyotrophic lateral sclerosis between Chinese and German populations
por: Tang, Lu, et al.
Publicado: (2021)

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
por: Abdelhak, Ahmed, et al.
Publicado: (2015)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis
por: Lindauer, Eva, et al.
Publicado: (2013)

Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry
por: Michels, Sebastian, et al.
Publicado: (2023)

Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
por: Freischmidt, Axel, et al.
Publicado: (2013)

Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis
por: Volk, Alexander E., et al.
Publicado: (2018)

Ethical Principles in Patient-Centered Medical Care to Support Quality of Life in Amyotrophic Lateral Sclerosis
por: Lulé, Dorothée, et al.
Publicado: (2019)

Multimodal in vivo staging in amyotrophic lateral sclerosis using artificial intelligence
por: Behler, Anna, et al.
Publicado: (2022)

Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosis
por: Ruf, Wolfgang P, et al.
Publicado: (2023)

Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis
por: Povedano Panades, Mónica, et al.
Publicado: (2021)

Quantifying Disease Progression in Amyotrophic Lateral Sclerosis
por: Simon, Neil G, et al.
Publicado: (2014)

Religiosity in patients with amyotrophic lateral sclerosis, a cross-country comparison
por: Ciećwierska, Katarzyna, et al.
Publicado: (2023)

Well-being in amyotrophic lateral sclerosis: a pilot experience sampling study
por: Real, Ruben G. L., et al.
Publicado: (2014)

Current and emerging treatments for amyotrophic lateral sclerosis
por: Zoccolella, Stefano, et al.
Publicado: (2009)

Cardiac Findings in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Imaging Study
por: Rosenbohm, Angela, et al.
Publicado: (2017)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot
por: Steinacker, Petra, et al.
Publicado: (2014)

ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale
por: Maier, André, et al.
Publicado: (2022)

Neuropsychological deficits have only limited impact on psychological well-being in amyotrophic lateral sclerosis
por: Schrempf, Till, et al.
Publicado: (2021)

Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis
por: Naumann, Marcel, et al.
Publicado: (2019)

Long-term survival analysis of masitinib in amyotrophic lateral sclerosis
por: Mora, Jesus S., et al.
Publicado: (2021)

Amygdala size in amyotrophic lateral sclerosis without dementia: an in vivo study using MRI volumetry
por: Pinkhardt, Elmar H, et al.
Publicado: (2006)

Longitudinal monitoring of amyotrophic lateral sclerosis by diffusion tensor imaging: Power calculations for group studies
por: Behler, Anna, et al.
Publicado: (2022)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Well‐being on supportive techniques in amyotrophic lateral sclerosis: from neurologists' perspective
por: Barć, Krzysztof, et al.
Publicado: (2022)

Incidence and Geographical Variation of Amyotrophic Lateral Sclerosis (ALS) in Southern Germany – Completeness of the ALS Registry Swabia
por: Uenal, Hatice, et al.
Publicado: (2014)

Are There Modifiable Environmental Factors Related to Amyotrophic Lateral Sclerosis?
por: Kuraszkiewicz, Bozenna, et al.
Publicado: (2018)

The use of P300-based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment
por: Cipresso, Pietro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n293da5p318v0l7jvsfige334a